Disease modeling and lentiviral gene transfer in patient-specific induced pluripotent stem cells from late-onset Pompe disease patient
Pompe disease is an autosomal recessive inherited metabolic disease caused by deficiency of acid α-glucosidase (GAA). Glycogen accumulation is seen in the affected organ such as skeletal muscle, heart, and liver. Hypertrophic cardiomyopathy is frequently seen in the infantile onset Pompe disease. O...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2015-01-01
|
| Series: | Molecular Therapy: Methods & Clinical Development |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2329050116300353 |
| _version_ | 1811268665357631488 |
|---|---|
| author | Yohei Sato Hiroshi Kobayashi Takashi Higuchi Yohta Shimada Takumi Era Shigemi Kimura Yoshikatsu Eto Hiroyuki Ida Toya Ohashi |
| author_facet | Yohei Sato Hiroshi Kobayashi Takashi Higuchi Yohta Shimada Takumi Era Shigemi Kimura Yoshikatsu Eto Hiroyuki Ida Toya Ohashi |
| author_sort | Yohei Sato |
| collection | DOAJ |
| description | Pompe disease is an autosomal recessive inherited metabolic disease caused by deficiency of acid α-glucosidase (GAA). Glycogen accumulation is seen in the affected organ such as skeletal muscle, heart, and liver. Hypertrophic cardiomyopathy is frequently seen in the infantile onset Pompe disease. On the other hand, cardiovascular complication of the late-onset Pompe disease is considered as less frequent and severe than that of infantile onset. There are few investigations which show cardiovascular complication of late onset Pompe disease due to the shortage of appropriate disease model. We have generated late-onset Pompe disease-specific induced pluripotent stem cell (iPSC) and differentiated them into cardiomyocytes. Differentiated cardiomyocyte shows glycogen accumulation and lysosomal enlargement. Lentiviral GAA rescue improves GAA enzyme activity and glycogen accumulation in iPSC. The efficacy of gene therapy is maintained following the cardiomyocyte differentiation. Lentiviral GAA transfer ameliorates the disease-specific change in cardiomyocyote. It is suggested that Pompe disease iPSC-derived cardiomyocyte is replicating disease-specific changes in the context of disease modeling, drug screening, and cell therapy. |
| first_indexed | 2024-04-12T21:26:55Z |
| format | Article |
| id | doaj.art-999ebf7eadb3414fa9228a6f2ae8b6c7 |
| institution | Directory Open Access Journal |
| issn | 2329-0501 |
| language | English |
| last_indexed | 2024-04-12T21:26:55Z |
| publishDate | 2015-01-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Molecular Therapy: Methods & Clinical Development |
| spelling | doaj.art-999ebf7eadb3414fa9228a6f2ae8b6c72022-12-22T03:16:08ZengElsevierMolecular Therapy: Methods & Clinical Development2329-05012015-01-012Disease modeling and lentiviral gene transfer in patient-specific induced pluripotent stem cells from late-onset Pompe disease patientYohei Sato0Hiroshi Kobayashi1Takashi Higuchi2Yohta Shimada3Takumi Era4Shigemi Kimura5Yoshikatsu Eto6Hiroyuki Ida7Toya Ohashi8Department of Pediatrics, The Jikei University School of Medicine, Tokyo, Japan; Division of Gene Therapy, Research Center for Medical Sciences, The Jikei University School of Medicine, Tokyo, JapanDepartment of Pediatrics, The Jikei University School of Medicine, Tokyo, Japan; Division of Gene Therapy, Research Center for Medical Sciences, The Jikei University School of Medicine, Tokyo, JapanDivision of Gene Therapy, Research Center for Medical Sciences, The Jikei University School of Medicine, Tokyo, JapanDivision of Gene Therapy, Research Center for Medical Sciences, The Jikei University School of Medicine, Tokyo, JapanDepartment of Cell Modulation, Institute of Molecular Embryology and Genetics, Kumamoto University, Kumamoto, JapanDepartment of Pediatrics, Kumamoto University Graduate School, Kumamoto, JapanAdvanced Clinical Research Center, Institute of Neurological Disorders, Kanagawa, JapanDepartment of Pediatrics, The Jikei University School of Medicine, Tokyo, Japan; Division of Gene Therapy, Research Center for Medical Sciences, The Jikei University School of Medicine, Tokyo, JapanDepartment of Pediatrics, The Jikei University School of Medicine, Tokyo, Japan; Division of Gene Therapy, Research Center for Medical Sciences, The Jikei University School of Medicine, Tokyo, JapanPompe disease is an autosomal recessive inherited metabolic disease caused by deficiency of acid α-glucosidase (GAA). Glycogen accumulation is seen in the affected organ such as skeletal muscle, heart, and liver. Hypertrophic cardiomyopathy is frequently seen in the infantile onset Pompe disease. On the other hand, cardiovascular complication of the late-onset Pompe disease is considered as less frequent and severe than that of infantile onset. There are few investigations which show cardiovascular complication of late onset Pompe disease due to the shortage of appropriate disease model. We have generated late-onset Pompe disease-specific induced pluripotent stem cell (iPSC) and differentiated them into cardiomyocytes. Differentiated cardiomyocyte shows glycogen accumulation and lysosomal enlargement. Lentiviral GAA rescue improves GAA enzyme activity and glycogen accumulation in iPSC. The efficacy of gene therapy is maintained following the cardiomyocyte differentiation. Lentiviral GAA transfer ameliorates the disease-specific change in cardiomyocyote. It is suggested that Pompe disease iPSC-derived cardiomyocyte is replicating disease-specific changes in the context of disease modeling, drug screening, and cell therapy.http://www.sciencedirect.com/science/article/pii/S2329050116300353 |
| spellingShingle | Yohei Sato Hiroshi Kobayashi Takashi Higuchi Yohta Shimada Takumi Era Shigemi Kimura Yoshikatsu Eto Hiroyuki Ida Toya Ohashi Disease modeling and lentiviral gene transfer in patient-specific induced pluripotent stem cells from late-onset Pompe disease patient Molecular Therapy: Methods & Clinical Development |
| title | Disease modeling and lentiviral gene transfer in patient-specific induced pluripotent stem cells from late-onset Pompe disease patient |
| title_full | Disease modeling and lentiviral gene transfer in patient-specific induced pluripotent stem cells from late-onset Pompe disease patient |
| title_fullStr | Disease modeling and lentiviral gene transfer in patient-specific induced pluripotent stem cells from late-onset Pompe disease patient |
| title_full_unstemmed | Disease modeling and lentiviral gene transfer in patient-specific induced pluripotent stem cells from late-onset Pompe disease patient |
| title_short | Disease modeling and lentiviral gene transfer in patient-specific induced pluripotent stem cells from late-onset Pompe disease patient |
| title_sort | disease modeling and lentiviral gene transfer in patient specific induced pluripotent stem cells from late onset pompe disease patient |
| url | http://www.sciencedirect.com/science/article/pii/S2329050116300353 |
| work_keys_str_mv | AT yoheisato diseasemodelingandlentiviralgenetransferinpatientspecificinducedpluripotentstemcellsfromlateonsetpompediseasepatient AT hiroshikobayashi diseasemodelingandlentiviralgenetransferinpatientspecificinducedpluripotentstemcellsfromlateonsetpompediseasepatient AT takashihiguchi diseasemodelingandlentiviralgenetransferinpatientspecificinducedpluripotentstemcellsfromlateonsetpompediseasepatient AT yohtashimada diseasemodelingandlentiviralgenetransferinpatientspecificinducedpluripotentstemcellsfromlateonsetpompediseasepatient AT takumiera diseasemodelingandlentiviralgenetransferinpatientspecificinducedpluripotentstemcellsfromlateonsetpompediseasepatient AT shigemikimura diseasemodelingandlentiviralgenetransferinpatientspecificinducedpluripotentstemcellsfromlateonsetpompediseasepatient AT yoshikatsueto diseasemodelingandlentiviralgenetransferinpatientspecificinducedpluripotentstemcellsfromlateonsetpompediseasepatient AT hiroyukiida diseasemodelingandlentiviralgenetransferinpatientspecificinducedpluripotentstemcellsfromlateonsetpompediseasepatient AT toyaohashi diseasemodelingandlentiviralgenetransferinpatientspecificinducedpluripotentstemcellsfromlateonsetpompediseasepatient |